Jingying Xu, Ph.D.
Affiliations: | 2010 | Neuroscience | University of Southern California, Los Angeles, CA, United States |
Area:
OncologyGoogle:
"Jingying Xu"Mean distance: 53433
Parents
Sign in to add mentor| Anat Erdreich-Epstein | grad student | 2010 | USC | |
| (Targeting tumor cells and microvessels in pediatric brain tumors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wu SG, Xu JY, Lei J, et al. (2023) Correction: Wu . Tumor-Suppressor Gene Transmembrane Protein 98 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer. Frontiers in Bioscience-Landmark. 2022; 27: 210. Frontiers in Bioscience (Landmark Edition). 28: 90 |
| Wu SG, Xu JY, Lei J, et al. (2022) Tumor-Suppressor Gene Transmembrane Protein 98 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer. Frontiers in Bioscience (Landmark Edition). 27: 210 |
| Zhu T, Wang T, Feng Z, et al. (2022) Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma. Frontiers in Oncology. 12: 880100 |
| Erdreich-Epstein A, Singh AR, Joshi S, et al. (2017) Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. 8: 52193-52210 |
| Xu J, Ren X, Pathania AS, et al. (2017) PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. Scientific Reports. 7: 835 |
| Erdreich-Epstein A, Singh AR, Joshi S, et al. (2016) Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget |
| Meade JC, Moore ZR, Stuart SH, et al. (2016) Abstract B39: NQO1 as a therapeutic target for atypical teratoid/ rhabdoid tumor Cancer Research. 76 |
| Xu J, Margol AS, Shukla A, et al. (2015) Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia. Frontiers in Oncology. 5: 191 |
| Weingart MF, Roth JJ, Hutt-Cabezas M, et al. (2015) Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget. 6: 3165-77 |
| Kaur H, Hütt-Cabezas M, Weingart MF, et al. (2015) The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. Journal of Neuropathology and Experimental Neurology. 74: 177-85 |